Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.000
-0.020 (-0.50%)
At close: Jun 1, 2026, 4:00 PM EDT
4.020
+0.020 (0.50%)
After-hours: Jun 1, 2026, 5:26 PM EDT
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $501.8 million as of June 1, 2026. Its market cap has increased by 127.57% in one year.
Market Cap
501.80M
Enterprise Value
435.90M
1-Year Change
127.57%
Ranking
Category
Stock Price
$4.00
Market Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has increased from $393.23M to $501.80M, an increase of 27.61%. That is a compound annual growth rate of 3.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 504.31M | -36.01% |
| Dec 31, 2025 | 788.14M | 142.81% |
| Dec 31, 2024 | 324.59M | 140.67% |
| Dec 29, 2023 | 134.87M | 176.07% |
| Dec 30, 2022 | 48.85M | -68.73% |
| Dec 31, 2021 | 156.24M | -13.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amphastar Pharmaceuticals | 831.15M |
| Esperion Therapeutics | 805.76M |
| BioAge Labs | 768.59M |
| Tilray Brands | 657.25M |
| Ironwood Pharmaceuticals | 587.67M |
| Emergent BioSolutions | 470.56M |
| Kamada | 455.27M |
| Evolus | 432.01M |